Bodscience
Contact Us Login
Logout
Do you really want to Logout?
  • About Us
    • Our Partners
    • Privacy Policy
    • Terms of Use
  • Research
    • Chronic Pain
    • Anxiety
    • Stress
    • Depression
    • Epilepsy
    • Arthritis
    • Inflammation
  • Investors
    • Investor Centre
    • Investment Highlights
    • ASX Announcements
    • Company Presentations
    • Corporate
    • Your Holdings
    • Media
  • Doctors
    • Doctor Support
    • Clinical Trials and Research
    • Collaboration
    • Our Medical Advisory Board
  • Medical Cannabis
    • How to Access
    • Medical Clinics
    • Find A Doctor
    • FAQ
  • Innovation
    • Aqua Phase
  • Pharmacy Ordering
    • Pharmacy Ordering
  • About Us
    • Our Partners
    • Privacy Policy
    • Terms of Use
  • Research
    • Chronic Pain
    • Anxiety
    • Stress
    • Depression
    • Epilepsy
    • Arthritis
    • Inflammation
  • Investors
    • Investor Centre
    • Investment Highlights
    • ASX Announcements
    • Company Presentations
    • Corporate
    • Your Holdings
    • Media
  • Doctors
    • Doctor Support
    • Clinical Trials and Research
    • Collaboration
    • Our Medical Advisory Board
  • Medical Cannabis
    • How to Access
    • Medical Clinics
    • Find A Doctor
    • FAQ
  • Innovation
    • Aqua Phase
  • Pharmacy Ordering
    • Pharmacy Ordering
Contact Us
  • INVESTORS
  • INVESTOR CENTRE
  • INVESTMENT HIGHLIGHTS
  • ASX ANNOUNCEMENTS
  • COMPANY PRESENTATIONS
  • CORPORATE
  • YOUR HOLDINGS
  • Media
  • Contact details

Media

$1.5 million R&D rebate bolsters cash balance

20 Dec 2022

Published by: Next Investors

View article
Bod strikes CBD over-the-counter deal with pharma firm Arrotex

02 Dec 2022

Published by: Cannabiz

View article
Quick Takes Company Updates Weekend Updates Educational Articles WA gold project update & what’s next?

02 Dec 2022

Published by: Next Investors

View article
Weed Week: Oregon pardons cannabis convictions and bulk people light up on Turkey Day

24 Nov 2022

Published by: Stockhead

View article
ASX Health Stocks: Pot stock BOD’s Phase 1 results; Paradigm and Impedimed shake up exec teams

22 Nov 2022

Published by: Stockhead

View article
National Nine News

04 Nov 2022

Published by: National Nine News

View article
Company news: Releaf Group; Bod; Wellnex Life; MGC Pharma; MediCann Health

27 Oct 2022

Published by: Cannabiz

View article
Weed and gold, the unloved investment thematics

22 Oct 2022

Published by: Next Investors

View article
Company news: Bod; Incannex; Medlab; Rua Bioscience; Emyria

20 Oct 2022

Published by: Cannabiz

View article
Patent lodged for anti-ageing skin process

20 Oct 2022

Published by: Next Investors

View article
❮❮❮34567❯❯❯
Bod Science
  • Privacy Policy
  • Terms of Use
  • Contact us
  • Sitemap

We’d like to use cookies and collect analytics to improve Snips’ websites.
You can find out more in our

Privacy Policy